Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

IQVIA Holdings (QTS) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
PegcetacoplanC3 Glomerulopathy (C3g), Immune Complex Membranoproliferative Glomerulonephritis (Ic-Mpgn)Phase IVRecruitingReal-World Effectiveness and Safety of Pegcetacoplan in Patients With C3G or IC-MPG: A Multi-Country StudyMar 26, 2026―
Noc-110Refractory Or Unexplained Chronic CoughPhase IIActive Not RecruitingStudy to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic CoughJul 11, 2024
Atozet 10/40 Mg Or 10/80 Mg, Lipitor 40 Mg Or 80 MgAtherosclerotic Cardiovascular DiseasePhase IVCompletedEffectiveness and Safety Study of Early add-on of Ezetimibe With Atorvastatin in Very High-risk PatientsFeb 27, 2023―
Avt05, SimponiHealthy Adult SubjectsPhase ICompletedA Study to Investigate the PK, Safety, and Tolerability Between AVT05, US and EU Simponi® in Healthy Adult ParticipantsNov 11, 2022―
Og-6219EndometriosisPhase IICompletedA Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related PainSep 20, 2022―
Olorofim, AmbisomeInvasive AspergillosisPhase IIIActive Not RecruitingOlorofim Aspergillus Infection StudySep 07, 2021―
Paclitaxel, Carboplatin, OregovomabOvarian Cancer, Ovarian Neoplasms, Peritoneal Carcinoma, Peritoneal Cancer, Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Peritoneal Neoplasms, Ovarian Serous Adenocarcinoma, Fallopian Tube Adenocarcinoma, Fallopian Tube Serous AdenocarcinomaPhase IIIActive Not RecruitingOregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking SurgeryJul 28, 2020―
Pembrolizumab, Ctx-471Melanoma, Non-small Cell Lung Cancer, Small Cell Lung Cancer, Metastatic Cancer, Head And Neck Cancer, Mesothelioma, Locally Advanced Solid TumorPhase ICompletedStudy of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced MalignanciesMar 13, 2019―
Imr-687Sickle Cell Disease, Sickle-Cell; Hb-Sc, Sickle Beta 0 ThalassemiaPhase ICompletedA Study of IMR-687 in Healthy Adult VolunteersDec 06, 2016―
3 G Or 6 G ZidebactamHealthy SubjectsPhase ICompletedMAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous Zidebactam in Healthy AdultsJan 25, 2016―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does IQVIA Holdings (CH:QTS) have in its pipeline
IQVIA Holdings CH:QTS is currently developing the following drugs: Pegcetacoplan, Noc-110, Atozet 10/40 Mg Or 10/80 Mg, Lipitor 40 Mg Or 80 Mg, Avt05, Simponi, Og-6219, Olorofim, Ambisome, Paclitaxel, Carboplatin, Oregovomab, Pembrolizumab, Ctx-471, Imr-687, 3 G Or 6 G Zidebactam, Leo 90105 = Calcipotriol + Betamethasone Dipropionate, Dovonex = Calcipotriol, Rinderon - Dp = Betamethasone Dipropionate, Leo 90105. These drug candidates are in various stages of clinical development as the company works toward FDA approval.